Boston Trust Walden’s Gentex GNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNTX
AI
EIG
CB
MIHAS
BGC
DGI
Boston Trust Walden's GNTX Position: Q3 2022 in Review
Boston Trust Walden sold out of Gentex (GNTX) in Q3 2022, closing a stake of 10,072 shares — an estimated $282K sold.
Boston Trust Walden first reported a position in GNTX in Q2 2021 and held it in 5 quarters. The position peaked at $351K in Q4 2021. 455 funds tracked by Wall St. Rank hold GNTX as of Q3 2022.
- Boston Trust Walden reported no remaining Gentex position as of Q3 2022 after selling out during the quarter.
- Boston Trust Walden sold 10,072 Gentex shares in Q3 2022, an estimated $282K.
- Boston Trust Walden first reported a position in Gentex in Q2 2021 and held it in 5 quarters.
- Boston Trust Walden's Gentex position peaked at $351K in Q4 2021.
- 455 funds tracked by Wall St. Rank held Gentex as of Q3 2022.
Based on Boston Trust Walden's 13F filing for Q3 2022, filed 19 Oct 2022.